Cerevel Therapeutics Ownership 2024 | Who Owns Cerevel Therapeutics Now?
Institutional Ownership
4.84%
Insider Ownership
15.32%
Retail Ownership
79.84%
Institutional Holders
71.00
Cerevel Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 36.17% | 57.02% | 65,679,781 | - | - | 2,685,646,245 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 5.94% | 10.48% | 10,794,876 | - | - | 441,402,480 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 4.15% | 4.11% | 7,539,547 | -16,008 | -0.21% | 308,292,077 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.94% | 0.01% | 7,154,343 | -309,568 | -4.15% | 292,541,085 | Jun 30, 2024 |
| BLACKROCK INC. | 1.96% | 0.00% | 3,560,931 | -1,887,689 | -34.65% | 145,606,470 | Jun 30, 2024 |
| FIL LTD | 1.79% | 0.13% | 3,252,000 | 3,000 | 0.09% | 132,974,280 | Jun 30, 2024 |
| STATE STREET CORP | 1.71% | 0.01% | 3,109,886 | -418,584 | -11.86% | 127,163,239,000 | Jun 30, 2024 |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1.30% | 4.60% | 2,353,694 | 12,300 | 0.53% | 96,242,547 | Jun 30, 2024 |
| NORGES BANK | 1.29% | 0.01% | 2,335,746 | 2,335,746 | 100.00% | 95,508,654 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.28% | 3.65% | 2,330,508 | - | - | 95,294,472 | Jun 30, 2024 |
| SOROS FUND MANAGEMENT LLC | 1.18% | 1.58% | 2,151,641 | 211,440 | 10.90% | 87,980,600 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.10% | 0.04% | 2,004,795 | 531,972 | 36.12% | 81,976,068 | Jun 30, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | 1.03% | 0.98% | 1,878,719 | -341,281 | -15.37% | 76,820,820 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.03% | 0.10% | 1,869,340 | 647,074 | 52.94% | 76,437,313 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.82% | 0.02% | 1,494,341 | 321,454 | 27.41% | 61,103,603 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.81% | 0.01% | 1,469,670 | -404,717 | -21.59% | 60,111,134 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.74% | 0.01% | 1,347,680 | 784,907 | 139.47% | 55,106,634 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.68% | 0.08% | 1,233,565 | 1,058,035 | 602.77% | 50,440,473 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.66% | 0.23% | 1,190,000 | 127,000 | 11.95% | 48,659,100 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.62% | 0.39% | 1,133,181 | 207,063 | 22.36% | 46,335,771 | Jun 30, 2024 |
Cerevel Therapeutics's largest institutional shareholder is BAIN CAPITAL INVESTORS LLC, holding 36.17% of the company's total share outstanding, currently valued at $2.69B. The top 10 institutional shareholders own together 59.53% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 36.17% | 57.02% | 65,679,781 | - | - | 2,685,646,245 | Jun 30, 2024 |
| TWIN SECURITIES, INC. | 0.23% | 13.40% | 416,657 | 315,381 | 311.41% | 17,037,105 | Jun 30, 2024 |
| SAND GROVE CAPITAL MANAGEMENT LLP | 0.51% | 10.99% | 919,023 | 919,023 | 100.00% | 37,578,850 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 5.94% | 10.48% | 10,794,876 | - | - | 441,402,480 | Jun 30, 2024 |
| P SCHOENFELD ASSET MANAGEMENT LP | 0.44% | 7.87% | 796,440 | 50,000 | 6.70% | 32,566,432 | Jun 30, 2024 |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1.30% | 4.60% | 2,353,694 | 12,300 | 0.53% | 96,242,547 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 4.15% | 4.11% | 7,539,547 | -16,008 | -0.21% | 308,292,077 | Jun 30, 2024 |
| MELQART ASSET MANAGEMENT (UK) LTD | 0.61% | 3.72% | 1,099,229 | 154,865 | 16.40% | 44,947,474 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.28% | 3.65% | 2,330,508 | - | - | 95,294,472 | Jun 30, 2024 |
| WATER ISLAND CAPITAL LLC | 0.42% | 3.33% | 766,933 | -21,937 | -2.78% | 31,360,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.28% | 2.36% | 500,000 | 200,000 | 66.67% | 20,445,000 | Jun 30, 2024 |
| VAZIRANI ASSET MANAGEMENT LLC | 0.01% | 2.18% | 25,000 | 25,000 | 100.00% | 1,022,250 | Jun 30, 2024 |
| GARDNER LEWIS ASSET MANAGEMENT L P | 0.11% | 2.15% | 192,150 | 70,000 | 57.31% | 7,857,014 | Jun 30, 2024 |
| CLEARALPHA TECHNOLOGIES LP | 0.08% | 2.02% | 149,438 | 62,320 | 71.54% | 6,110,520 | Jun 30, 2024 |
| TIG ADVISORS, LLC | 0.32% | 1.73% | 588,255 | 565,359 | 2469.25% | 24,053,747 | Jun 30, 2024 |
| TRIUM CAPITAL LLP | 0.17% | 1.64% | 317,731 | 317,731 | 100.00% | 12,992,000 | Jun 30, 2024 |
| SOROS FUND MANAGEMENT LLC | 1.18% | 1.58% | 2,151,641 | 211,440 | 10.90% | 87,980,600 | Jun 30, 2024 |
| OLYMPIAD RESEARCH LP | 0.03% | 1.58% | 52,423 | 5,119 | 10.82% | 2,143,576 | Jun 30, 2024 |
| STANSBERRY ASSET MANAGEMENT, LLC | 0.16% | 1.51% | 281,694 | 91,906 | 48.43% | 11,518,467 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.05% | 1.45% | 97,200 | - | - | 3,974,508 | Jun 30, 2024 |
The largest Cerevel Therapeutics shareholder by % of total assets is BAIN CAPITAL INVESTORS LLC. The company owns 65.68M shares of Cerevel Therapeutics (CERE), representing 57.02% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 1.29% | 0.01% | 2,335,746 | 2,335,746 | 100.00% | 95,508,654 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.68% | 0.08% | 1,233,565 | 1,058,035 | 602.77% | 50,440,473 | Jun 30, 2024 |
| SAND GROVE CAPITAL MANAGEMENT LLP | 0.51% | 10.99% | 919,023 | 919,023 | 100.00% | 37,578,850 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.74% | 0.01% | 1,347,680 | 784,907 | 139.47% | 55,106,634 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.42% | 0.01% | 756,000 | 654,600 | 645.56% | 30,912,840 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.03% | 0.10% | 1,869,340 | 647,074 | 52.94% | 76,437,313 | Jun 30, 2024 |
| TIG ADVISORS, LLC | 0.32% | 1.73% | 588,255 | 565,359 | 2469.25% | 24,053,747 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.44% | 0.28% | 801,600 | 550,600 | 219.36% | 32,777,424 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.10% | 0.04% | 2,004,795 | 531,972 | 36.12% | 81,976,068 | Jun 30, 2024 |
| GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC | 0.28% | 0.07% | 508,838 | 508,838 | 100.00% | 20,806,386 | Jun 30, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | 0.22% | 0.21% | 400,000 | 400,000 | 100.00% | 16,356,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.25% | 0.03% | 446,018 | 354,333 | 386.47% | 18,237,676 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.82% | 0.02% | 1,494,341 | 321,454 | 27.41% | 61,103,603 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.21% | 0.09% | 377,431 | 320,816 | 566.66% | 15,433,000 | Jun 30, 2024 |
| TRIUM CAPITAL LLP | 0.17% | 1.64% | 317,731 | 317,731 | 100.00% | 12,992,000 | Jun 30, 2024 |
| TWIN SECURITIES, INC. | 0.23% | 13.40% | 416,657 | 315,381 | 311.41% | 17,037,105 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.16% | 0.02% | 288,200 | 288,200 | 100.00% | 11,784,498 | Jun 30, 2024 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 0.14% | 0.22% | 260,399 | 260,399 | 100.00% | 10,647,715 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.14% | 0.16% | 260,000 | 260,000 | 100.00% | 10,631,400 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.38% | 0.00% | 697,510 | 257,344 | 58.47% | 28,521,183 | Jun 30, 2024 |
As of Jun 30 2024, Cerevel Therapeutics's largest institutional buyer is NORGES BANK. The company purchased 2.34M stocks of CERE, valued at $95.51M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 1.96% | 0.00% | 3,560,931 | -1,887,689 | -34.65% | 145,606,470 | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 4,880 | -1,787,470 | -99.73% | 199,560 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 0.38% | 0.36% | 683,588 | -916,412 | -57.28% | 27,951,913 | Jun 30, 2024 |
| MAN GROUP PLC | 0.19% | 0.03% | 337,271 | -640,275 | -65.50% | 13,791,011 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.00% | 0.00% | 5,925 | -566,542 | -98.97% | 242,273 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -564,044 | -100.00% | - | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -547,946 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.33% | 0.04% | 596,407 | -480,808 | -44.63% | 24,387,082 | Jun 30, 2024 |
| STATE STREET CORP | 1.71% | 0.01% | 3,109,886 | -418,584 | -11.86% | 127,163,239,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.81% | 0.01% | 1,469,670 | -404,717 | -21.59% | 60,111,134 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.02% | 0.00% | 44,442 | -377,573 | -89.47% | 1,817,233 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.26% | 0.05% | 466,823 | -361,953 | -43.67% | 19,088,392 | Jun 30, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | 1.03% | 0.98% | 1,878,719 | -341,281 | -15.37% | 76,820,820 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.94% | 0.01% | 7,154,343 | -309,568 | -4.15% | 292,541,085 | Jun 30, 2024 |
| GABELLI FUNDS LLC | 0.19% | 0.11% | 347,624 | -296,235 | -46.01% | 14,214,345 | Jun 30, 2024 |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 0.09% | 1.12% | 164,345 | -283,350 | -63.29% | 6,720,067 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.03% | 0.00% | 53,401 | -281,956 | -84.08% | 2,184,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.18% | 0.13% | 335,500 | -264,501 | -44.08% | 13,718,595 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | - | - | - | -253,495 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.18% | 0.00% | 330,728 | -182,763 | -35.59% | 13,523,503 | Jun 30, 2024 |
As of Jun 30 2024, Cerevel Therapeutics's biggest institutional seller is BLACKROCK INC.. The company sold -1.89M shares of CERE, valued at $145.61M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 1.29% | 0.01% | 2,335,746 | 2,335,746 | 100.00% | 95,508,654 | Jun 30, 2024 |
| SAND GROVE CAPITAL MANAGEMENT LLP | 0.51% | 10.99% | 919,023 | 919,023 | 100.00% | 37,578,850 | Jun 30, 2024 |
| GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC | 0.28% | 0.07% | 508,838 | 508,838 | 100.00% | 20,806,386 | Jun 30, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | 0.22% | 0.21% | 400,000 | 400,000 | 100.00% | 16,356,000 | Jun 30, 2024 |
| TRIUM CAPITAL LLP | 0.17% | 1.64% | 317,731 | 317,731 | 100.00% | 12,992,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.16% | 0.02% | 288,200 | 288,200 | 100.00% | 11,784,498 | Jun 30, 2024 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 0.14% | 0.22% | 260,399 | 260,399 | 100.00% | 10,647,715 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.14% | 1.18% | 250,000 | 250,000 | 100.00% | 10,222,500 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 0.11% | 0.10% | 201,743 | 201,743 | 100.00% | 8,249,271 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.11% | 0.00% | 200,000 | 200,000 | 100.00% | 8,178,000 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 0.11% | 0.01% | 200,000 | 200,000 | 100.00% | 287,499 | Jun 30, 2024 |
| TIG ADVISORS, LLC | 0.09% | 0.48% | 164,000 | 164,000 | 100.00% | 6,705,960 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.06% | 0.31% | 110,010 | 110,010 | 100.00% | 4,498,309 | Jun 30, 2024 |
| MURCHINSON LTD. | 0.06% | 0.63% | 100,000 | 100,000 | 100.00% | 4,089,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.05% | 0.00% | 87,100 | 87,100 | 100.00% | 3,561,519 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.04% | 0.18% | 78,576 | 78,576 | 100.00% | 3,212,973 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.04% | 0.07% | 73,395 | 73,395 | 100.00% | 3,001,122 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.03% | 0.36% | 50,000 | 50,000 | 100.00% | 2,044,500 | Jun 30, 2024 |
| P SCHOENFELD ASSET MANAGEMENT LP | 0.03% | 0.49% | 50,000 | 50,000 | 100.00% | 2,044,500 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 42,761 | 42,761 | 100.00% | 1,745,781 | Jun 30, 2024 |
| MOORE CAPITAL MANAGEMENT, LP | 0.02% | 0.03% | 42,600 | 42,600 | 100.00% | 1,741,914 | Jun 30, 2024 |
| GLAZER CAPITAL, LLC | 0.02% | 0.13% | 40,000 | 40,000 | 100.00% | 1,636,000 | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | 0.02% | 0.28% | 36,000 | 36,000 | 100.00% | 1,472,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.02% | 0.00% | 35,000 | 35,000 | 100.00% | 1,431,150 | Jun 30, 2024 |
| TREASURER OF THE STATE OF NORTH CAROLINA | 0.02% | 0.01% | 30,010 | 30,010 | 100.00% | 1,227,000 | Jun 30, 2024 |
| HUNTING HILL GLOBAL CAPITAL, LLC | 0.02% | 0.54% | 30,000 | 30,000 | 100.00% | 1,226,700 | Jun 30, 2024 |
| EISLER CAPITAL (US) LLC | 0.01% | 0.02% | 25,000 | 25,000 | 100.00% | 1,022,250 | Jun 30, 2024 |
| VAZIRANI ASSET MANAGEMENT LLC | 0.01% | 0.08% | 25,000 | 25,000 | 100.00% | 38,750 | Jun 30, 2024 |
| VAZIRANI ASSET MANAGEMENT LLC | 0.01% | 2.18% | 25,000 | 25,000 | 100.00% | 1,022,250 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.01% | 0.11% | 24,220 | 24,220 | 100.00% | 990,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.01% | 0.00% | 24,000 | 24,000 | 100.00% | 981,000 | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | 0.01% | 0.09% | 12,001 | 12,001 | 100.00% | 491,000 | Jun 30, 2024 |
| FMR LLC | 0.01% | - | 10,000 | 10,000 | 100.00% | 408,900 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.01% | 0.01% | 9,268 | 9,268 | 100.00% | 378,969 | Jun 30, 2024 |
| CRYSTALLINE MANAGEMENT INC. | 0.00% | 0.35% | 8,918 | 8,918 | 100.00% | 364,657 | Jun 30, 2024 |
| XPONANCE, INC. | 0.00% | 0.00% | 8,638 | 8,638 | 100.00% | 353,208 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.00% | 0.01% | 8,417 | 8,417 | 100.00% | 344,171 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.00% | 0.01% | 8,089 | 8,089 | 100.00% | 330,759 | Jun 30, 2024 |
| FIFTH LANE CAPITAL, LP | 0.00% | 0.44% | 7,500 | 7,500 | 100.00% | 306,675 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.00% | 0.00% | 7,361 | 7,361 | 100.00% | 300,991 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | 0.00% | 7,051 | 7,051 | 100.00% | 288,000 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.00% | 0.00% | 6,782 | 6,782 | 100.00% | 277,316 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.00% | 0.14% | 6,693 | 6,693 | 100.00% | 273,677 | Jun 30, 2024 |
| DRW SECURITIES, LLC | 0.00% | 0.01% | 5,900 | 5,900 | 100.00% | 230,784 | Jun 30, 2024 |
| MARYLAND STATE RETIREMENT & PENSION SYSTEM | 0.00% | 0.00% | 5,372 | 5,372 | 100.00% | 219,661 | Jun 30, 2024 |
| CIBC ASSET MANAGEMENT INC | 0.00% | 0.00% | 5,092 | 5,092 | 100.00% | 208,212 | Jun 30, 2024 |
| QUINN OPPORTUNITY PARTNERS LLC | 0.00% | 0.02% | 5,000 | 5,000 | 100.00% | 204,450 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | 0.00% | 4,285 | 4,285 | 100.00% | 175,214 | Jun 30, 2024 |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. | 0.00% | 0.04% | 3,107 | 3,107 | 100.00% | 127,044 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.00% | 0.00% | 1,372 | 1,372 | 100.00% | 56,101 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.00% | 0.00% | 1,200 | 1,200 | 100.00% | 49,068 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | 0.00% | 1,128 | 1,128 | 100.00% | 46,124 | Jun 30, 2024 |
| BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 265 | 265 | 100.00% | 10,836 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 145 | 145 | 100.00% | 5,872 | Jun 30, 2024 |
| - | 0.00% | 78 | 78 | 100.00% | 3,189 | Jun 30, 2024 |
Cerevel Therapeutics's largest new institutional shareholder by number of shares is NORGES BANK, purchased 2.34M shares, valued at $95.51M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -564,044 | -100.00% | - | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | - | - | - | -547,946 | -100.00% | - | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | - | - | - | -253,495 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -128,068 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -35,294 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -31,526 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -19,700 | -100.00% | - | Jun 30, 2024 |
| DLD ASSET MANAGEMENT, LP | - | - | - | -16,500 | -100.00% | - | Jun 30, 2024 |
| BLACK MAPLE CAPITAL MANAGEMENT LP | - | - | - | -15,702 | -100.00% | - | Jun 30, 2024 |
| TEZA CAPITAL MANAGEMENT LLC | - | - | - | -13,507 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -10,100 | -100.00% | - | Jun 30, 2024 |
| GREENLAND CAPITAL MANAGEMENT LP | - | - | - | -8,960 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -8,500 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -7,236 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -5,099 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,833 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -2,400 | -100.00% | - | Jun 30, 2024 |
| CSS LLC/IL | - | - | - | -2,000 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -423 | -100.00% | - | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
Cerevel Therapeutics's largest sold out institutional shareholder by shares sold is VOLORIDGE INVESTMENT MANAGEMENT, LLC, sold -0.56M shares, valued at -, as of undefined.
Cerevel Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Virtus Event Opportunities Trust | 1.87% | 4,701,000 | 2,420,000 | 106.09% | Mar 28, 2024 |
| Manager Directed Portfolios | 1.61% | 263,159 | - | - | Jan 31, 2024 |
| MERGER FUND VL | 1.29% | 191,000 | 91,000 | 91.00% | Mar 28, 2024 |
| MERGER FUND | 1.15% | 9,317,000 | 5,619,000 | 151.95% | Mar 28, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.57% | 1,903,967 | - | - | Mar 31, 2024 |
| Gabelli 787 Fund, Inc. | 0.51% | 44,000 | 44,000 | - | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.38% | 1,887,585 | - | - | Mar 31, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.28% | 259,397 | - | - | Jan 31, 2024 |
| BNY MELLON VARIABLE INVESTMENT FUND | 0.27% | 65,067 | - | - | Mar 31, 2024 |
| AltShares Trust | 0.23% | 41,924 | 41,924 | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.16% | 1,352,758 | - | - | Jan 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.16% | 74,161 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.15% | 542,090 | - | - | Mar 31, 2024 |
| Comstock Funds, Inc. | 0.14% | 3,000 | 3,000 | - | Jan 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.12% | 102,322 | - | - | Mar 31, 2024 |
| ARBITRAGE FUNDS | 0.12% | 545,183 | 545,183 | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 47,300 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.08% | 221,156 | - | - | Mar 31, 2024 |
| MERGER FUND | 0.07% | 592,960 | 31,990 | 5.70% | Mar 28, 2024 |
| IndexIQ ETF Trust | 0.07% | 161,850 | 161,850 | - | Jan 31, 2024 |
| MERGER FUND VL | 0.07% | 10,109 | 397 | 4.09% | Mar 28, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.07% | 214,200 | -274,000 | -56.12% | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.07% | 16,659 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.06% | 1,835,635 | -7,823,974 | -81.00% | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.06% | 1,204,539 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.05% | 1,203 | -221 | -15.52% | Dec 31, 2023 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.05% | 424,765 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.05% | 88,189 | - | - | Mar 31, 2024 |
| GDL FUND | 0.04% | 53,000 | 53,000 | - | Dec 29, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 100,000 | - | - | Mar 31, 2024 |
| Virtus Event Opportunities Trust | 0.04% | 91,786 | 5,473 | 6.34% | Mar 28, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 98,513 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.03% | 1,941,302 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.03% | 275,887 | -6,769 | -2.39% | Jan 31, 2024 |
| GABELLI INVESTOR FUNDS INC | 0.03% | 66,000 | 66,000 | - | Dec 29, 2023 |
| FIDELITY CAPITAL TRUST | 0.02% | 267,500 | - | - | Jan 31, 2024 |
| ACAP Strategic Fund | 0.02% | 346,148 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 240,454 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 123,419 | -3,455 | -2.72% | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.02% | 246,209 | 242,909 | 7360.88% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,651 | -2 | -0.02% | Mar 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.02% | 2,012 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 6,522,517 | -1,264,159 | -16.23% | Mar 31, 2024 |
| HARBOR FUNDS | 0.02% | 347,870 | -217,950 | -38.52% | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 29,952 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 41,803 | 682 | 1.66% | Feb 29, 2024 |
| Nushares ETF Trust | 0.01% | 63,563 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.01% | 10,230 | 10,193 | 27548.65% | Dec 31, 2023 |
| ALPS ETF Trust | 0.01% | 105,293 | -5,957 | -5.35% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.01% | 154,000 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,443 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 450,200 | - | - | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 315,244 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 199,923 | 17,039 | 9.32% | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 18,841 | 18,277 | 3240.60% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 884,878 | 21,580 | 2.50% | Feb 29, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 200,000 | - | - | Feb 29, 2024 |
| SMALLCAP WORLD FUND INC | 0.00% | 253,495 | -610,191 | -70.65% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 276,900 | - | - | Jan 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 32,164 | - | - | Feb 29, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 306,460 | 306,460 | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 18,984 | - | - | Aug 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.00% | 640,000 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,236 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 26,522 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust II | 0.00% | 2,510 | 2,510 | - | Feb 29, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 10,433 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,895 | - | - | Jan 31, 2024 |
| AB PORTFOLIOS | 0.00% | 38,155 | 38,155 | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 348,400 | - | - | Feb 29, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 24,211 | - | - | Feb 29, 2024 |
| ETF Managers Trust | 0.00% | 11,400 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 45,471 | -3,490 | -7.13% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 17,604 | -1,448 | -7.60% | Mar 31, 2024 |
| LITMAN GREGORY FUNDS TRUST | 0.00% | 94,330 | 36,685 | 63.64% | Mar 31, 2024 |
| NEUBERGER BERMAN ALTERNATIVE FUNDS | 0.00% | 16,695 | 16,695 | - | Jan 31, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 97,526 | - | - | Aug 31, 2023 |
| JANUS INVESTMENT FUND | 0.00% | 396,675 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 254,974 | -26,072 | -9.28% | Feb 29, 2024 |
| ProFunds | 0.00% | 11,843 | 3,324 | 39.02% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 21,622 | 503 | 2.38% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 135,830 | -20,475 | -13.10% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 464,336 | 15,443 | 3.44% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 22,820 | -4,734 | -17.18% | Mar 31, 2024 |
| Global X Funds | 0.00% | 31,545 | 3,700 | 13.29% | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,404 | 34 | 1.01% | Mar 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 4,566 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 506 | 18 | 3.69% | Jan 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 4,900 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 5,756 | 1,353 | 30.73% | Mar 31, 2024 |
| CREDIT SUISSE OPPORTUNITY FUNDS | 0.00% | 21,015 | 21,015 | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 25,800 | 1,100 | 4.45% | Mar 31, 2024 |
| SCHWAB INVESTMENTS | 0.00% | 20,827 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 982 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 2,700 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 3,133 | - | - | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 1,507 | - | - | Jan 31, 2024 |
| Harbor ETF Trust | 0.00% | 1,464 | - | - | Jan 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 7,674 | - | - | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 2,177 | 2,177 | - | Mar 28, 2024 |
Cerevel Therapeutics's largest mutual fund holder by % of total assets is "Virtus Event Opportunities Trust", owning 4.70M shares, compromising 1.87% of its total assets.
Cerevel Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 71 | -68.72% |
| 31 Mar, 24 | 227 | -0.87% |
| 31 Dec, 23 | 229 | 77.52% |
| 30 Sep, 23 | 129 | -5.15% |
| 30 Jun, 23 | 136 | 0.74% |
| 31 Mar, 23 | 135 | -6.25% |
| 31 Dec, 22 | 144 | 19.01% |
| 30 Sep, 22 | 121 | 3.42% |
| 30 Jun, 22 | 117 | 3.54% |
| 31 Mar, 22 | 113 | -1.74% |
| 31 Dec, 21 | 115 | 11.65% |
| 30 Sep, 21 | 103 | 10.75% |
| 30 Jun, 21 | 93 | 52.46% |
| 31 Mar, 21 | 61 | 7.02% |
| 31 Dec, 20 | 57 | - |
As of 30 Jun 24, 71 institutions are holding Cerevel Therapeutics's shares, representing a decrease of -68.72% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 8,781,183 | -94.24% |
| 31 Mar, 24 | 152,401,068 | -1.12% |
| 31 Dec, 23 | 154,125,073 | 9.92% |
| 30 Sep, 23 | 140,209,416 | 1.37% |
| 30 Jun, 23 | 138,319,720 | 2.17% |
| 31 Mar, 23 | 135,381,888 | 1.05% |
| 31 Dec, 22 | 133,972,289 | 0.73% |
| 30 Sep, 22 | 132,998,038 | 7.13% |
| 30 Jun, 22 | 124,149,414 | 1.69% |
| 31 Mar, 22 | 122,083,826 | 2.93% |
| 31 Dec, 21 | 118,611,990 | -0.42% |
| 30 Sep, 21 | 119,109,100 | 15.28% |
| 30 Jun, 21 | 103,324,787 | 3.45% |
| 31 Mar, 21 | 99,883,531 | 3.45% |
| 31 Dec, 20 | 96,549,247 | - |
Cerevel Therapeutics (CERE) has 8.78M shares outstanding as of 30 Jun 24, down -94.24% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 4.84% | 0.05% |
| 31 Mar, 24 | 94.04% | 0.98% |
| 31 Dec, 23 | 97.86% | 1.23% |
| 30 Sep, 23 | 89.28% | 1.15% |
| 30 Jun, 23 | 88.30% | 1.18% |
| 31 Mar, 23 | 86.42% | 1.18% |
| 31 Dec, 22 | 85.67% | 1.12% |
| 30 Sep, 22 | 87.32% | 1.25% |
| 30 Jun, 22 | 83.72% | 1.23% |
| 31 Mar, 22 | 82.50% | 1.09% |
| 31 Dec, 21 | 86.85% | 1.27% |
| 30 Sep, 21 | 82.70% | 1.26% |
| 30 Jun, 21 | 81.05% | 1.32% |
| 31 Mar, 21 | 78.51% | 1.00% |
| 31 Dec, 20 | 88.47% | - |
As of 30 Jun 24, Cerevel Therapeutics is held by 4.84% institutional shareholders, representing a 0.05% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 33 | -72.73% |
| 31 Mar, 24 | 121 | -21.43% |
| 31 Dec, 23 | 154 | 90.12% |
| 30 Sep, 23 | 81 | 15.71% |
| 30 Jun, 23 | 70 | 22.81% |
| 31 Mar, 23 | 57 | -33.72% |
| 31 Dec, 22 | 86 | 4.88% |
| 30 Sep, 22 | 82 | 17.14% |
| 30 Jun, 22 | 70 | 29.63% |
| 31 Mar, 22 | 54 | -23.94% |
| 31 Dec, 21 | 71 | -2.74% |
| 30 Sep, 21 | 73 | 25.86% |
| 30 Jun, 21 | 58 | 48.72% |
| 31 Mar, 21 | 39 | -31.58% |
| 31 Dec, 20 | 57 | - |
33 institutional shareholders have increased their position in CERE stock as of 30 Jun 24 compared to 121 in the previous quarter (a -72.73% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 15 | -71.70% |
| 31 Mar, 24 | 53 | 51.43% |
| 31 Dec, 23 | 35 | 40.00% |
| 30 Sep, 23 | 25 | -43.18% |
| 30 Jun, 23 | 44 | 10.00% |
| 31 Mar, 23 | 40 | 48.15% |
| 31 Dec, 22 | 27 | 42.11% |
| 30 Sep, 22 | 19 | -26.92% |
| 30 Jun, 22 | 26 | -27.78% |
| 31 Mar, 22 | 36 | 33.33% |
| 31 Dec, 21 | 27 | 68.75% |
| 30 Sep, 21 | 16 | -11.11% |
| 30 Jun, 21 | 18 | 50.00% |
| 31 Mar, 21 | 12 | - |
| 31 Dec, 20 | - | - |
15 institutional shareholders have reduced their position in CERE stock as of 30 Jun 24 compared to 53 in the previous quarter (a -71.70% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 71 | -68.72% | 8,781,183 | -94.24% | 4.84% | 0.05% | 33 | -72.73% | 15 | -71.70% |
| 31 Mar, 24 | 227 | -0.87% | 152,401,068 | -1.12% | 94.04% | 0.98% | 121 | -21.43% | 53 | 51.43% |
| 31 Dec, 23 | 229 | 77.52% | 154,125,073 | 9.92% | 97.86% | 1.23% | 154 | 90.12% | 35 | 40.00% |
| 30 Sep, 23 | 129 | -5.15% | 140,209,416 | 1.37% | 89.28% | 1.15% | 81 | 15.71% | 25 | -43.18% |
| 30 Jun, 23 | 136 | 0.74% | 138,319,720 | 2.17% | 88.30% | 1.18% | 70 | 22.81% | 44 | 10.00% |
| 31 Mar, 23 | 135 | -6.25% | 135,381,888 | 1.05% | 86.42% | 1.18% | 57 | -33.72% | 40 | 48.15% |
| 31 Dec, 22 | 144 | 19.01% | 133,972,289 | 0.73% | 85.67% | 1.12% | 86 | 4.88% | 27 | 42.11% |
| 30 Sep, 22 | 121 | 3.42% | 132,998,038 | 7.13% | 87.32% | 1.25% | 82 | 17.14% | 19 | -26.92% |
| 30 Jun, 22 | 117 | 3.54% | 124,149,414 | 1.69% | 83.72% | 1.23% | 70 | 29.63% | 26 | -27.78% |
| 31 Mar, 22 | 113 | -1.74% | 122,083,826 | 2.93% | 82.50% | 1.09% | 54 | -23.94% | 36 | 33.33% |
| 31 Dec, 21 | 115 | 11.65% | 118,611,990 | -0.42% | 86.85% | 1.27% | 71 | -2.74% | 27 | 68.75% |
| 30 Sep, 21 | 103 | 10.75% | 119,109,100 | 15.28% | 82.70% | 1.26% | 73 | 25.86% | 16 | -11.11% |
| 30 Jun, 21 | 93 | 52.46% | 103,324,787 | 3.45% | 81.05% | 1.32% | 58 | 48.72% | 18 | 50.00% |
| 31 Mar, 21 | 61 | 7.02% | 99,883,531 | 3.45% | 78.51% | 1.00% | 39 | -31.58% | 12 | - |
| 31 Dec, 20 | 57 | - | 96,549,247 | - | 88.47% | - | 57 | - | - | - |
Cerevel Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Cerevel Therapeutics's stock was made by PFIZER INC on Aug 05 2024, selling 27,349,211 shares at $45.00 per share (valued at $1.23B).
Cerevel Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 2 | 50.00% |
| Q2 2024 | 12 | 6 | 200.00% |
| Q1 2024 | 14 | 11 | 127.27% |
| Q4 2023 | 26 | 39 | 66.67% |
| Q3 2023 | 6 | 4 | 150.00% |
| Q2 2023 | 25 | 14 | 178.57% |
| Q1 2023 | 20 | 10 | 200.00% |
| Q4 2022 | 5 | 9 | 55.56% |
| Q3 2022 | 13 | 27 | 48.15% |
| Q2 2022 | 16 | 3 | 533.33% |
| Q1 2022 | 15 | 19 | 78.95% |
| Q4 2021 | 10 | 20 | 50.00% |
| Q3 2021 | 6 | 2 | 300.00% |
| Q2 2021 | 10 | 1 | 1000.00% |
| Q1 2021 | 12 | 2 | 600.00% |
| Q4 2020 | 24 | 26 | 92.31% |
| Q2 2020 | 2 | 4 | 50.00% |
| Q4 2017 | - | 2 | - |
| Q1 2014 | 2 | - | - |
| Q1 2013 | 2 | - | - |
1 total buy trades, and 2 total sell trades (buy/sell ratio of 0.50%) were made by Cerevel Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | 4 | 18 | 22.22% |
| Q3 2023 | 2 | 2 | 100.00% |
| Q2 2023 | - | 7 | - |
| Q1 2023 | - | 6 | - |
| Q4 2022 | - | 4 | - |
| Q3 2022 | 3 | 13 | 23.08% |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | 7 | - |
| Q4 2021 | - | 12 | - |
| Q3 2021 | 5 | - | - |
| Q2 2021 | 1 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 11 | - | - |
| Q2 2020 | - | - | - |
| Q4 2017 | - | - | - |
| Q1 2014 | - | - | - |
| Q1 2013 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Cerevel Therapeutics's stocks.
Cerevel Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| NUVL | Nuvalent, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| IKNA | Ikena Oncology, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| MLYS | Mineralys Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| RNA | Avidity Biosciences, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| IGMS | IGM Biosciences, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| GPCR | Structure Therapeutics Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| SWTX | SpringWorks Therapeutics, Inc. |
CERE Ownership FAQ
Who Owns Cerevel Therapeutics?
Cerevel Therapeutics is owned by institutional shareholders (4.84%), insiders (15.32%), and public (79.84%). The largest institutional shareholder of Cerevel Therapeutics is BAIN CAPITAL INVESTORS LLC (36.17% of total shares) and the top mutual fund owner is Virtus Event Opportunities Trust (1.87% of total shares).
Who are the major institutional shareholders of Cerevel Therapeutics?
Cerevel Therapeutics's major institutional shareholders are BAIN CAPITAL INVESTORS LLC, PERCEPTIVE ADVISORS LLC, AVORO CAPITAL ADVISORS LLC, VANGUARD GROUP INC, and BLACKROCK INC.. The top five shareholders own together 52.16% of the company's share outstanding.
How many Cerevel Therapeutics shareholders are there?
As of Jun 2024, there are 71 institutional shareholders of Cerevel Therapeutics.
What percentage of Cerevel Therapeutics is owned by BAIN CAPITAL INVESTORS LLC?
BAIN CAPITAL INVESTORS LLC owns 65.68M shares of Cerevel Therapeutics, representing 36.17% of the company's total shares outstanding, valued at $2.69B (as of Jun 2024).
What percentage of Cerevel Therapeutics is owned by PERCEPTIVE ADVISORS LLC?
As of Jun 2024, PERCEPTIVE ADVISORS LLC holds 10.79M shares of Cerevel Therapeutics (CERE), compromising 5.94% of the company, valued at $441.4M.
What percentage of Cerevel Therapeutics is owned by AVORO CAPITAL ADVISORS LLC?
AVORO CAPITAL ADVISORS LLC is the third largest holder of Cerevel Therapeutics. The company owns 7.54M of the company's shares outstanding (worth $308.29M).